Five things for pharma marketers to know: Thursday, June 14, 2018

BIO afterparty again sparks controversy; GSK meets goal for two-drug HIV treatment; Mylan receives complete response letter for Advair generic.

from Most popular articles from Medical Marketing and Media https://ift.tt/2t9zJDU